Title of article
Trp-P-1, a carcinogenic heterocyclic amine, inhibits lipopolysaccharide-induced maturation and activation of human dendritic cells
Author/Authors
Jeon، نويسنده , , Jun Ho and Kim، نويسنده , , Sun Kyung and Im، نويسنده , , Jintaek and Ahn، نويسنده , , Ki Bum and Baik، نويسنده , , Jung Eun and Park، نويسنده , , Ok-Jin and Yun، نويسنده , , Cheol-Heui and Han، نويسنده , , Seung Hyun، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2011
Pages
12
From page
63
To page
74
Abstract
Carcinogens frequently provoke immunosuppressive effects thereby allowing cancer cells to persist in the host. 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) is a carcinogenic heterocyclic amine that is abundantly produced by overcooking meat and fish. Here, we investigated the effect of Trp-P-1 on dendritic cells (DCs), which play a central role in the appropriate activation of the host immune system. When human monocyte-derived DCs were stimulated with lipopolysaccharide (LPS), the DCs became mature with an increase in the expression of co-stimulatory receptors such as CD80, CD86, and MHC molecules and a decrease in phagocytic capacity. Trp-P-1 inhibited all of these phenomena under the same conditions. In addition, Trp-P-1 inhibited production of the cytokines TNF-α and IL-12 in LPS-stimulated DCs. Furthermore, DCs that were pre-exposed to Trp-P-1 were less efficient in inducing activation and proliferation of autologous T cells than control DCs. Trp-P-1 also attenuated the ability of DCs to directly kill T-cell lymphoma Jurkat cells. Mechanism studies showed that Trp-P-1 did not inhibit LPS-binding to Toll-like receptor 4 but interfered with the signaling pathways mediated through p38 kinase. In conclusion, our results suggest that Trp-P-1 is immunosuppressive by inhibiting the functionality of DCs that play an essential role in the appropriate induction of anti-cancer immune responses.
Keywords
innate immunity , dendritic cells , Trp-P-1 , Heterocyclic Amines , immunosuppression , carcinogen
Journal title
Cancer Letters
Serial Year
2011
Journal title
Cancer Letters
Record number
1819523
Link To Document